Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

583 Articles

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Oct 5, 2015 at 8:20 AM EDT

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Credit Suisse is adding some top conservative dividend-paying stocks to its Top Picks list, and that is right in line…

Chris Lange | Sep 25, 2015 at 8:40 AM EDT

Short Sellers Boost Positions in Major Pharma

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 11, 2015 at 8:25 AM EDT

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…

Chris Lange | Sep 10, 2015 at 4:18 PM EDT

AbbVie Posts Another Win for Humira

ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in…

Chris Lange | Aug 26, 2015 at 8:05 AM EDT

Short Sellers Have Mixed Feelings on Major Pharma

The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Lee Jackson | Aug 18, 2015 at 8:22 AM EDT

4 Top Pharma Stocks That Should Outperform Out To 2016

ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for…

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2015 at 3:19 PM EDT

Why AbbVie Should Be Worth 25% More

Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

Chris Lange | Jul 24, 2015 at 9:10 AM EDT

Are AbbVie Earnings Enough?

AbbVie reported better-than-expected second-quarter financial results Friday before the markets opened.

Chris Lange | Jul 23, 2015 at 1:25 PM EDT

What to Expect From AbbVie Earnings

Abbvie is scheduled to report its second-quarter financial results before the markets open Friday.

Paul Ausick | Jul 20, 2015 at 9:35 AM EDT

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been…

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

1 … 32 33 34 35 36 … 39

AbbVie : ABBV

All AbbVie Articles

Short Sellers Become More Selective on Major Pharma

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

AbbVie Posts Another Win for Humira

Short Sellers Have Mixed Feelings on Major Pharma

4 Top Pharma Stocks That Should Outperform Out To 2016

Short Sellers Back Off Big Pharma

Why AbbVie Should Be Worth 25% More

Short Sellers Run For Cover From Major Pharma

Are AbbVie Earnings Enough?

What to Expect From AbbVie Earnings

Top Health Care Earnings for the Week Ahead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

AbbVie : ABBV

All AbbVie Articles

Short Sellers Become More Selective on Major Pharma

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

AbbVie Posts Another Win for Humira

Short Sellers Have Mixed Feelings on Major Pharma

4 Top Pharma Stocks That Should Outperform Out To 2016

Short Sellers Back Off Big Pharma

Why AbbVie Should Be Worth 25% More

Short Sellers Run For Cover From Major Pharma

Are AbbVie Earnings Enough?

What to Expect From AbbVie Earnings

Top Health Care Earnings for the Week Ahead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation